Clinical trial
Clinical Translation and Application Protocol for ZVS101e in the Gene Therapy of Bietti Crystalline Corneoretinal Dystrophy
NCT07653971 is registered in ClinicalTrials.gov with Chigenovo Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Translation and Application Protocol for ZVS101e in the Gene Therapy of Bietti Crystalline Corneoretinal Dystrophy
- Lead sponsor
- Chigenovo Co., Ltd
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- December 31, 2035
- Enrollment
- 300 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
bietti crystalline corneoretinal dystrophy, bietti's crystalline dystrophy